2-N-(5-[[4-(2-METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE

Title:

2-N-(5-[[4-(2-METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE

Document Type and Number:

WIPO Patent Application WO2007130064

Kind Code:

A8

Abstract:

Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.

More Like This:

WO/2005/033079	NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND
JP6049617	The pyrimidine derivative as FAK inhibitor
WO/2014/086894	MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

Inventors:

DOLITZKY YEHUDIT (IL)
AVEZOV YOSEPH (IL)
SPIVAK DINA (IL)
LEIBOVICI MINUTZA (IL)
SOLOMON BEN-ZION (IL)

Application Number:

PCT/US2006/017994

Publication Date:

February 21, 2008

Filing Date:

May 09, 2006

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TEVA PHARMA (US)
TEVA PHARMA (US)
DOLITZKY YEHUDIT (IL)
AVEZOV YOSEPH (IL)
SPIVAK DINA (IL)
LEIBOVICI MINUTZA (IL)
SOLOMON BEN-ZION (IL)

International Classes:

C07D417/12

Download PDF:

View/Download PDF PDF Help

Previous Patent: FRONT-LOADING MEDICAL INJECTOR AND SYRINGES FOR USE THEREWITH

Next Patent: A CORRECTION METHOD, APPARATUS, DATA CARRIER OR SYSTEM FOR CORRECTING FOR UNINTENDED SPATIAL VARIATI...